Classification and market path
Clarify how the device, intended purpose, risk profile, and proposed market position affect the regulatory route and the work the program needs to support.
MEDICAL DEVICE CE MARKING CONSULTING
Medical Device CE Marking Consulting
Bring classification, evidence, technical documentation, and quality work into one clear plan for the European market.
Discuss your European market plan →THE PLAN BEFORE THE FILE
Prepare for Europe with a program that holds together.
CE marking is not a document assembled at the end of development. It is the visible outcome of decisions about the device, its intended purpose, classification, clinical evidence, risk controls, technical documentation, and quality-system responsibilities. When those decisions are made on separate tracks, teams can end up revisiting work late, explaining inconsistent records, or discovering that a key assumption does not support the market plan.
Qualira helps medical-device teams connect those workstreams before the path becomes expensive to change. The focus is practical: understand the device and the commercial objective, identify the decisions that set the evidence burden, and create a proportionate plan that the organization can carry into execution.
WHERE QUALIRA HELPS
Senior support for the decisions that shape European market readiness.
Evidence and clinical strategy
Connect clinical evaluation, performance evidence, risk management, usability, and other supporting work to the claims and questions the device needs to answer.
Technical documentation
Bring the device description, benefit-risk rationale, verification and validation evidence, labeling, and supporting records into a coherent device story.
Quality and lifecycle readiness
Align quality-system responsibilities, post-market planning, changes, suppliers, and internal ownership so readiness is not limited to a single submission milestone.
A CONNECTED REGULATORY CASE
Make each workstream support the same decision.
A credible European market plan starts with an honest view of the device and the claims the business needs to support. Classification, intended purpose, clinical evidence, performance testing, risk management, and labeling all influence one another. If any one of them changes, the team needs to understand what else must move with it.
Qualira helps make those dependencies visible early. For a new product, that can mean shaping the market plan before technical, clinical, or documentation choices become fixed. For an established device, it can mean assessing the existing record, prioritizing the gaps that matter to the next milestone, and giving the internal team a workable sequence for closing them.
The right engagement is not always the largest one. Some teams need ongoing regulatory leadership across the program. Others need a targeted assessment, additional capacity around a defined deliverable, or a senior perspective before they commit to a path. Qualira meets the team at the decision where clearer judgment will protect time, budget, and options.
WHAT THE TEAM NEEDS TO KNOW
Reduce uncertainty before it spreads through the program.
Teams preparing for the European market are often balancing an ambitious commercial objective with incomplete information: an intended purpose still being refined, clinical evidence collected for a different question, technical documentation built over time, or a quality system that has not yet caught up with the product. The practical work is deciding what needs to be resolved now, what evidence truly strengthens the case, and how to keep decisions consistent across functions.
Intended purpose and claims
The intended purpose sets the frame for classification, evidence, labeling, and the claims a team can support. Qualira helps teams make this foundation specific enough to guide the rest of the program without overreaching beyond the available evidence.
Evidence that answers the right questions
Clinical, performance, risk, and usability evidence should be planned around the device and its intended use, not collected as disconnected checklist items. A focused strategy helps the team concentrate effort where it makes the case more credible.
Documentation that tells one coherent story
Technical documentation is easier to review and maintain when its underlying records agree. Qualira helps connect the product description, risks, verification and validation, clinical rationale, labeling, and lifecycle planning around the same device position.
Operational readiness after the milestone
European market readiness does not end when a file is completed. Quality ownership, supplier controls, change management, post-market activity, and internal accountability need to remain workable as the device evolves.
PRACTICAL PROGRAM EXPERIENCE
Bring senior perspective to the decisions that will be hard to unwind later.
Qualira brings regulatory, clinical, quality, and technical expertise into one conversation because the strongest regulatory case is built through connected decisions. The team can help a company translate a broad market ambition into the specific work that needs to be planned, owned, documented, and maintained.
That approach is useful whether the need is an early pathway assessment, a focused review of what exists today, or hands-on support as a program moves toward a European milestone. The goal is not a generic template. It is a plan that reflects the device, its evidence, and the decisions the business needs to make next.
View client outcomes →A USEFUL FIRST CONVERSATION
Bring the European market question that is slowing the program down.
What intended purpose, claims, and classification assumptions should guide this device's European market plan?
Which evidence and records need to be reliable before we commit to the next milestone?
Where are clinical, technical, regulatory, and quality workstreams making incompatible assumptions?
Do we need a long-term partner, targeted support, or an independent readiness review?
FREQUENTLY ASKED QUESTIONS
Frequently asked questions
When should a medical device team bring in CE marking support?
Bring in senior support before the intended purpose, classification, evidence plan, or technical documentation becomes difficult to change. Early involvement gives the team more room to align the device, quality system, clinical evidence, and market plan before the work becomes a late-stage documentation exercise.
Can Qualira help if our device is already developed?
Yes. A focused review can help an established team identify the decisions, evidence, records, or quality-system work that need attention before a European market milestone. The appropriate scope depends on the device, intended purpose, existing documentation, and the gaps that could affect the path forward.
Is CE marking only a regulatory-documentation task?
No. The documentation needs to reflect the real product and the controls behind it. Classification, intended purpose, clinical evaluation, risk management, technical documentation, labeling, post-market planning, and quality-system responsibilities need to support the same device story.
Can Qualira work alongside our internal team or other specialists?
Yes. Qualira can add senior regulatory, clinical, quality, or technical perspective to an existing program, helping the workstreams connect around the decisions that matter most. The goal is to strengthen the program already underway, not create unnecessary layers.
TALK WITH QUALIRA